SCHEMBL30583155

SCHEMBL30583155

Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CC2CC2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 1.00
MAPK13 O15264 4/20 0.64
MAPK12 P53778 4/20 0.64
MAPK11 Q15759 4/20 0.64
CSNK1D P48730 2/20 0.63
EGFR P00533 1/20 0.63
CSNK1E P49674 1/20 0.63
KCNH2 Q12809 1/20 0.63
RIPK2 O43353 1/20 0.61
DYRK3 O43781 1/20 0.61
PRKD3 O94806 1/20 0.61
MAP4K4 O95819 1/20 0.61
PRKCG P05129 1/20 0.61
LCK P06239 1/20 0.61
LYN P07948 1/20 0.61
RET P07949 1/20 0.61
PIM1 P11309 1/20 0.61
PRKACA P17612 1/20 0.61
MAPK1 P28482 1/20 0.61
FLT4 P35916 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4323457 1.00 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL20551142 0.96 MAPK14 (0.92) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL20550892 0.95 MAPK14 (0.90) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL23795652 0.92 MAPK14 (0.84) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL20550895 0.83 MAPK14 (0.71) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL4323452 0.82 MAPK14 (0.70) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL29842089 0.81 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL23795663 0.81 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL4916578 0.81 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL30023277 0.81 MAPK14 (0.87) MAPK14MAPK13MAPK12MAPK11CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed